
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Are you Dr. Patel?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Keyur Patel, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Connecticut.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Molecular Genetic Pathology, 2009 - 2010
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Hematopathology, 2008 - 2009
- N.H.L Municipal Medical CollegeClass of 1999
Certifications & Licensure
- TX State Medical License 2010 - 2025
- CT State Medical License 2008 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Clinical Informatics
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review.Karen Amelia Nahmod, Roberto N Miranda, Francisco Vega, Beenu Thakral, Naveen Pemmaraju
Leukemia & Lymphoma. 2025-04-01 - 1 citationsMicrosatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistoc...Richard K Yang, Hector Alvarez, Antony San Lucas, Sinchita Roy-Chowdhuri, Asif Rashid
Cancer Genetics. 2025-01-01 - Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy.Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, Naifa L Busaidy, Priyanka Iyer
JCO Precision Oncology. 2025-01-01
Press Mentions
- Liquid Biopsy’s Promise and ComplexitiesMarch 25th, 2025
- Combination Therapy Shown as Effective for Higher-Risk DS/AML PatientsDecember 7th, 2014